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Mortality by Cardiorespiratory Fitness Levels
Measured at Ages 45, 55, and 65 Years in Men
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Jarett D. Berry, MD, MS,* Benjamin Willis, MD, MPH,† Sachin Gupta, MD,*
Carolyn E. Barlow, MS,† Susan G. Lakoski, MD, MS,* Amit Khera, MD, MS,* Anand Rohatgi, MD,*
James A. de Lemos, MD,* William Haskell, PHD,‡ Donald M. Lloyd-Jones, MD, SCM§
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Objectives The purpose of this study was to determine the association between fitness and lifetime risk for cardiovascular
disease (CVD).
Background Higher levels of traditional risk factors are associated with marked differences in lifetime risks for CVD. How-
ever, data are sparse regarding the association between fitness and the lifetime risk for CVD.
Methods We followed up 11,049 men who underwent clinical examination at the Cooper Institute in Dallas, Texas, before
1990 until the occurrence of CVD death, non-CVD death, or attainment of age 90 years (281,469 person-years
of follow-up, median follow-up 25.3 years, 1,106 CVD deaths). Fitness was measured by the Balke protocol and
categorized according to treadmill time into low, moderate, and high fitness, with further stratification by CVD
risk factor burden. Lifetime risk for CVD death determined by the National Death Index was estimated for fitness
levels measured at ages 45, 55, and 65 years, with non-CVD death as the competing event.
Results Differences in fitness levels (low fitness vs. high fitness) were associated with marked differences in the lifetime risks
for CVD death at each index age: age 45 years, 13.7% versus 3.4%; age 55 years, 34.2% versus 15.3%; and age 65
years, 35.6% versus 17.1%. These associations were strongest among persons with CVD risk factors.
Conclusions A single measurement of low fitness in mid-life was associated with higher lifetime risk for CVD death, particu-
larly among persons with a high burden of CVD risk factors. (J Am Coll Cardiol 2011;57:1604–10) © 2011 by
the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.10.056Despite a substantial decline in cardiovascular disease
(CVD) death rates over the past 3 decades (1), CVD
remains the leading cause of mortality in the United States.
Moreover, recent data suggest that unfavorable lifestyle
trends promoting weight gain are leading to an increase in
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accepted October 19, 2010.some CVD risk factors such as diabetes mellitus, obesity,
and metabolic syndrome, which may halt or even reverse the
favorable trends in CVD death (1). For example, only 1 in
2 adults achieve recommended moderate or vigorous activity
levels in a given week (2). Therefore, more effective public
health and clinical strategies are needed to communicate the
importance of lifestyle factors such as physical activity in
preventing CVD.
Prior research has demonstrated an independent, dose-
dependent, inverse association between cardiorespiratory
fitness and CVD outcomes among persons with and with-
out CVD at baseline (3–7). While the consistency of these
data provide support for the protective role of fitness, the
reporting of these associations as absolute or relative risk
estimates has well-recognized limitations for risk commu-
nication strategies (8–11). Therefore, national guidelines
suggest clinicians consider current risk factor burden within
the context of long-term or lifetime risk for CVD (12–14).
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April 12, 2011:1604–10 Lifetime Risk and Physical FitnessWe and others have reported the association between
traditional risk factors (i.e., smoking, diabetes, cholesterol,
and blood pressure) and lifetime risks for CVD (15–17).
However, it is unknown whether a single measurement of
fitness in mid-life is associated with lifetime risks for CVD
many years later. In addition, the combined effect of fitness
and traditional risk factors on lifetime risks for CVD
mortality is also unknown.
Therefore, the purpose of the present study was to
determine the association between fitness measured at ages
45, 55, and 65 years and the lifetime risks for CVD death
using a well-characterized cohort from the CCLS (Cooper
Center Longitudinal Study) with objectively measured fit-
ness data. Because of the large sample size and long-term
follow-up needed to create lifetime risk estimates, to our
knowledge, this cohort represents 1 of the only available
datasets to conduct such analyses.
Methods
We included 11,049 men who underwent clinical examina-
tion at the Cooper Institute in Dallas, Texas, before 1990.
Because of the long-term follow-up and large number of
events required for lifetime risk analyses, we included men
60 years of age with an initial examination before 1985
and men 60 to 69 years of age with an initial examination
before 1990. These persons were either self-referred or were
referred by their employer or personal physician. Details of
the clinical examination and the study cohort have been
published previously (3,4). Participants completed a com-
prehensive clinical examination that included a self-reported
personal and family history, standardized medical examina-
tion by a physician, fasting blood levels of total cholesterol,
triglycerides, and glucose, and a maximal treadmill exercise
test. Body mass index was calculated from measured height
and weight. Participants signed an informed consent for the
clinical examinations and follow-up, and the study was
reviewed and approved annually by the institutional review
board of the Cooper Institute as well as by the University of
Texas Southwestern Medical Center.
Because the purpose of the present analysis is to deter-
mine the association between fitness levels and lifetime risks
for CVD death, all participants were included in the study
sample regardless of medical history. In addition, no one
was excluded on the basis of performance on the exercise
treadmill portion of the examination. Women were not
included in the present analysis because of the small
numbers and low event rates, which precluded the possibil-
ity of creating reliable estimates of lifetime risk.
As reported previously (3,4), fitness was measured in the
CCLS cohort by a maximal treadmill exercise test using a
Balke protocol. In this protocol, treadmill speed is set
initially at 88 m/min. In the first minute, the grade is set at
0%, followed by 2% in the second minute, and an increase of
1% for every minute thereafter. After 25 min, the grade
remains unchanged but the speed is increased by 5.4 m/min foreach additional minute until the
test is terminated. Participants
were encouraged not to hold onto
the railing and were given encour-
agement to exert maximal effort.
The test was terminated by voli-
tional exhaustion reported by the
participant or by the physician
for medical reasons. As de-
scribed previously, the test time
using this protocol correlates highly with directly mea-
sured maximal oxygen uptake (r  0.92) (18). Using
well-characterized regression equations, treadmill times
from the Balke protocol allow for estimation of fitness
level in metabolic equivalents (METs) (18).
Mortality surveillance. Study participants were followed
up for mortality from the date of the initial, complete
clinical examination through 2006. Before 1979, follow-up
was completed by direct mail, telephone, contact with
employer, and matching of records with Social Security
Administration files. After the development of the National
Death Index in 1979, all-cause mortality and deaths due to
CVD (as indicated by International Classification of Dis-
eases [ICD]-9 codes 390.0 to 458.9, or equivalent codes
from ICD-8 or -10) were included in the primary analysis.
Additional details regarding follow-up of the CCLS cohort
have been described previously in detail (3,4).
Statistical analyses. We grouped participants according to
fitness levels and risk factor levels as measured within 5
ears from 1 of 3 index ages: 45 years, 55 years, and 65 years.
or example, fitness levels and traditional risk factors measured
etween ages 40 and 49 years were included in the age 45
nalyses. To estimate the lifetime risks of CVD mortality in
ifferent risk groups, participants were categorized according to
) levels of fitness; 2) levels of traditional risk factors; and 3)
ombinations of fitness/traditional risk factor burden.
In accordance with standard approaches to the analysis
f fitness data (3,4), treadmill times were compared with
ge- and sex-specific normative data on treadmill perfor-
ance within the CCLS cohort, allowing each person’s
readmill time to be classified into an age- and sex-
pecific quintile of fitness. These quintiles of fitness
easures were then combined into 3 mutually exclusive
tness groupings: low fitness, quintile 1; moderate fit-
ess, quintiles 2 and 3; and high fitness, quintiles 4 and
. Where sample size allowed, additional analyses were
erformed among men with “very low fitness,” defined as
6 METs.
Participants were stratified by baseline traditional risk
actor burden using our previously published algorithm
16,19). Using this method, we stratified participants a
riori into 5 mutually exclusive risk factor categories exclu-
ive of medication data: all optimal risk factor levels,1 not
optimal risk factors, 1 elevated risk factors, 1 major risk
factor only, or 2 major risk factors (see table footnotes for
Abbreviations
and Acronyms
CVD  cardiovascular
disease
LRPP  Lifetime Risk
Pooling Project
MET  metabolic
equivalentdetails).
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Lifetime Risk and Physical Fitness April 12, 2011:1604–10Participants were also stratified according to combina-
tions of fitness and traditional risk factor burden as follows.
First, fitness was categorized dichotomously as low fit
(quintile 1) versus high fit (quintiles 2 to 5). Next, tradi-
tional risk factor burden was also analyzed categorically
using our recently published algorithm and classified for the
purpose of these analyses as “high risk burden” (1 elevated
risk factors, 1 major risk factor, or 2 major risk factors)
and “low risk burden” (all optimal risk factor levels, 1 not
ptimal risk factors) (19). By combining traditional risk
actor burden with the 2 levels of fitness, we were able to
reate 4 mutually exclusive risk groups at each index age: low
isk burden/low fit; high risk burden/low fit; low risk
urden/high fit; and high risk burden/high fit.
We calculated lifetime risk for CVD death for each risk
roup (as defined in the preceding text) using a modified
echnique of survival analysis, as described previously
20,21). In this type of analysis, participants contributed
nformation on the incidence of CVD and death free of
VD for each age they attained during follow up.
ecause the Kaplan-Meier cumulative incidence does not
eflect the competing risk for death from other causes
efore development of CVD, adjustment was made for
his competing risk to yield a true remaining lifetime risk
or CVD. Therefore, significant differences between the
ifetime risk estimate and the Kaplan-Meier estimate for
VD death suggest the importance of competing risks.
ecause of the unstable estimates that result when
ge-specific follow-up becomes limited, the follow-up
eriod was truncated when weighted person-years were
90 for a given age of follow-up.
In an effort to compare lifetime risks in the CCLS cohort
ith prior lifetime risk estimates obtained from more
epresentative cohorts, we compared lifetime risks for CVD
eath by traditional risk factor categories in the CCLS
ohorts with lifetime risks for CVD death in the cardiovas-
ular Lifetime Risk Pooling Project (LRPP) (22). The
RPP represents a pooled analysis of 16 cohorts represent-
ng 64,907 participants from some of the most prominent
bservational cohorts in the United States in the past 50
ears. All statistical analyses were performed using SAS for
indows (version 9.2, SAS Institute, Cary, North Carolina).
esults
e included 11,049 men who were 40 to 69 years of age
ho had both traditional risk factor measurement and
xercise treadmill tests performed before 1990. During
81,469 person-years of follow-up through 2006, there were
,054 CVD deaths and 1,736 non-CVD deaths. The
aseline characteristics of the study cohort stratified by
evels of age and fitness are shown in Table 1. As expected,
lder age was associated with a higher prevalence of diabe-
es, a lower prevalence of current smoking, higher blood
ressure, and generally lower total cholesterol levels. Within
ach age strata, higher levels of fitness were associated with Ba T
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1
s
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April 12, 2011:1604–10 Lifetime Risk and Physical Fitnesslower levels of traditional risk factors. In addition, because
we used age-specific cutpoints for fitness levels, the mean
METs within a given fitness level were higher at younger
ages (i.e., age 45 years [moderate fit], 10.8 METs vs. age 65
years [moderate fit], 8.3 METs).
Lifetime risks for CVD death by traditional risk factor
levels. To compare the lifetime risks in the CCLS cohort
with other cohorts, we determined the lifetime risks for
CVD death stratified by traditional risk factor burden using
our previously published algorithm (16,19). As expected,
higher levels of traditional risk factors was associated with a
higher lifetime risk for CVD death in the CCLS cohort.
Although the estimates were lower for men at age 45 years,
the lifetime risk estimates for CVD death for men at age 55
years and at 65 years were overall quite similar to those
estimates obtained from the LRPP, a pooled lifetime risk
analysis of 16 unique study cohorts representing 64,907
persons (22) (Table 2).
Lifetime risks and survival for CVD death by fitness
levels. Lifetime risks for CVD death to ages 80 and 90
years stratified by fitness levels measured at each index age
are shown in Table 3. For each age group, lower levels of
fitness were associated with higher lifetime risks for CVD
death. Although in the first 10 years, the risk for CVD
death was similar for all fitness levels (Fig. 1), there were
Comparison of Lifetime Risks* for Cardiovascular Disease Death bMeasu ed at Ages 45, 55, and 65 Years (Men) in the CCLS and thTable 2 Comparison of Lifetime Risks* for Card ov cular DiseMeasured at Ages 45, 55, and 65 Years (Men) in the
All Optimal RFs Not Optimal RFs
Age 45 yrs
Lifetime risks, CCLS, % 0.46 (0–1.4) 4.8 (1.8–7.5)
Lifetime risks, LRPP, % 9.1 (0–18.6) 13.1 (9.9–16.3)
Age 55 yrs
Lifetime risks, CCLS, % 16.6 (0–33.1) 17.0 (6.3–24.5)
Lifetime risks, LRPP, % 17.0 (6.8–27.3) 20.7 (16.9–24.5)
Age 65 yrs
Lifetime risks, CCLS, % 23.2 (0–46.5) 22.5 (13.3–30.2)
Lifetime risks, LRPP, % — 18.4 (14.5–22.0)
Data are presented as % (95% confidence interval). Empty cells in the table represent strata for w
RFs” was defined as total cholesterol 180 mg/dl, blood pressure 120/80 mm Hg, nonsmok
80 to 200mg/dl, systolic blood pressure 120 to 140mmHg, or diastolic blood pressure 80 to 90m
ystolic blood pressure 140 to 160 mm Hg or diastolic blood pressure 90 to 100 mm Hg. “Major
Hg, or diastolic blood pressure 100 mm Hg. *Lifetime risks to age 80 years (for age 45 years) a
CCLS  Cooper Center Longitudinal Study; LRPP  Lifetime Risk Pooling Project; RF  risk fac
Lifetime Risk for Cardiovascular Disease Death Stratified by FitnesMeasured at Ages 45, 55, and 65 Years in the Cooper Center LongTable 3 Lifetime Risk for Card ov cular Disease Death StratifiMeasured at Ages 45, 55, and 65 Years in the Cooper
Age
Lifetime Risk to Age 80 Years
High Fitness
(n  2,687)
Moderate Fitness
(n  4,785)
Low Fitness
(n  3,577)
V
45 yrs 3.4 (1.7–4.9) 6.2 (4.6–7.6) 12.2 (9.7–14.2)
55 yrs 4.9 (3.4–6.3) 9.8 (8.1–11.3) 19.6 (16.5–22.4)
65 yrs 5.6 (3.5–7.6) 8.8 (6.0–11.4) 12.2 (6.7–17.4)Data are presented as % (95% confidence interval). Empty cells in the table represent strata for which no
years for age 45 years group. †Metabolic equivalents 6.marked differences in the lifetime risk for CVD death across
the remaining lifespan.
Lifetime risks for CVD death by both traditional risk
factor burden and fitness. When participants were strati-
fied by aggregate risk factor burden and fitness level, the
lifetime risk for CVD death was lowest in the high fit/low
risk burden group for risk factors measured at each index age
(Fig. 2). The lifetime risks were highest for persons with
both low fitness level and high levels of traditional risk
factors at each index age. In contrast, the lifetime risks were
intermediate for groups with either low fitness or high
traditional risk factors risk, but not both.
Competing risks across the lifespan. Compared with
Kaplan-Meier cumulative incidence data for CVD death,
adjustment for competing causes of death resulted in a
decrease in the lifetime risks for CVD death across all age,
fitness, and risk factor groups studied (data not shown). The
evidence for competing risks was most prominent at older
ages and at lower levels of fitness, at which the rates of
non-CVD death are highest. For example, among men with
high fitness levels measured at age 55 years, the lifetime
risks for CVD death were similar to the unadjusted, Kaplan
Meier estimate (Kaplan-Meier cumulative incidence 13.1%
vs. lifetime risk 11.5%). In contrast, among men age 55
years with very low fitness levels (6 METs), the unad-
itional Risk Factor Burdenrdiovascular LRPPeath by Traditional Risk Factor Burden
and the Cardiovascular LRPP
Risk Factor Status
>1 Elevated RF 1 Major RF >2 Major RFs
7.5 (4.8–9.8) 8.5 (6.9–10.0) 12.5 (8.7–15.7)
15.3 (13.3–17.4) 20.7 (19.4–22.2) 32.5 (30.5–34.5)
17.0 (11.3–21.3) 23.3 (11.3–21.3) 35.6 (27.6–41.7)
29.5 (27.2–31.8) 32.3 (30.9–33.7) 41.4 (39.6–43.2)
20.6 (15.0–25.2) 29.6 (23.3–34.9) 37.1 (26.1–46.3)
27.7 (25.3–30.2) 33.6 (31.9–35.3) 42.2 (40.0–44.4)
reliable estimates of lifetime risks could be made secondary to small sample sizes. “All Optimal
nondiabetic. “Not Optimal RFs” was defined as nonsmoker and nondiabetic with total cholesterol
“Elevated RF” was defined as nonsmoker and nondiabetic with total cholesterol 200 to 240mg/dl,
s defined as current smoker or total cholesterol 240 mg/dl, systolic blood pressure 160 mm
0 years (for ages 55 years and 65 years).
elnal StudyFitness Level
ter Longitudinal Study
Lifetime Risk to Age 90 Years*
w Fitness†
 174)
High Fitness
(n  2,687)
Moderate Fitness
(n  4,785)
Low Fitness
(n  3,577)
— 3.4 (1.7–4.9) 7.5 (5.1–9.6) 13.7 (9.8–16.6)
7.2–39.1) 15.3 (10.1–19.2) 19.7 (15.0–23.1) 34.2 (27.1–39.0)
6.1–23.3) 17.1(12.0–21.2) 25.1 (19.5–29.7) 35.6 (26.5–43.7)y Trade Case D
CCLS
hich no
er, and
m Hg.
RF” was Levitudied by
Cen
ery Lo
(n
28.7 (1
15.2 (reliable estimates of lifetime risks could be made secondary to small sample sizes. *To age 85
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Lifetime Risk and Physical Fitness April 12, 2011:1604–10Figure 1 Lifetime Risks for CVD Death
by Cardiorespiratory Fitness
Lifetime risks for cardiovascular disease (CVD) death in men stratified by car-
diorespiratory fitness measured at age (A) 45 years, (B) 55 years, and (C) 65
years. Treadmill times were compared with normative data on treadmill perfor-
mance, allowing treadmill time to be classified into an age-specific quintile of
fitness. Quintile 1 was defined as “low fit” (red triangles), quintiles 2 and 3 as
“moderate fit” (blue squares), and quintiles 4 and 5 as “high fit” (green cir-
cles). See the Methods section for details.Figure 2 Lifetime Risks for CVD Death by
Cardiorespiratory Fitness and Risk Burden
Lifetime risks for cardiovascular disease (CVD) death stratified by cardiorespiratory
fitness and risk factor burden measured at age (A) 45 years, (B) 55 years, and
(C) 65 years. Quintile 1 was defined as “low fit,” and quintiles 2 through 5 were
defined as “high fit.” “Low risk burden” was defined as the combined presence of
nonsmoking status and nondiabetic status with total cholesterol 200 mg/dl, sys-
tolic blood pressure 140 mm Hg, and diastolic blood pressure 90 mm Hg.
“High risk burden” was defined as the presence of 1 or more of the following: cur-
rent smoker, diabetes mellitus, total cholesterol 200 mg/dl, systolic blood pres-
sure 140 mm Hg, and/or diastolic blood pressure 90 mm Hg. See the
Methods section for details. At age 65 years, the sample size was insufficient to
create reliable lifetime risk estimates for the low fit/low risk factor burden group.
Red triangles indicate low fit, high risk burden; blue squares indicate low fit, low
risk burden; down-pointing purple triangles indicate high fit, high risk burden;
green circles indicate high fit, low risk burden.
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April 12, 2011:1604–10 Lifetime Risk and Physical Fitnessjusted Kaplan-Meier estimate was higher than the lifetime
risk estimate adjusted for competing risk (Kaplan-Meier 
44.0%, lifetime risk  35.7%).
Discussion
We observed several important findings in this study. First,
the lifetime risks for CVD death according to traditional
risk factors in the CCLS were similar to those obtained in
a larger, more representative cohort. Thus, although the risk
factor burden is lower in the CCLS cohort compared with
the general population, the association of these risk factors
with lifetime risks for CVD mortality was quite similar,
particularly for men at ages 55 and 65 years. Second, low
fitness obtained from a single fitness measurement was
associated with marked differences in the lifetime risks for
CVD death 30 years later. Finally, the combination of
high fitness with a high traditional risk factor burden was
associated with a lifetime risk for CVD death that was
comparable to that of a person with low risk burden.
Multiple prior studies have shown that a single measure-
ment of cholesterol or blood pressure in mid-life was
associated with marked differences in CVD risk across 30 or
more years of follow-up (16,23,24). The findings in the
present study extend these observations to physical fitness.
Despite the effects of interval changes in fitness over time,
the presence of a single measurement of low physical fitness
in mid-life translated into a 15% to 20% absolute difference
in the lifetime risk for CVD death.
Furthermore, among persons with elevated cholesterol,
hypertension, diabetes, or current smoking status, the pres-
ence of a higher fitness level in mid-life attenuated substan-
tially the risk from traditional risk factors. These data have
potential implications for public health and clinical practice,
providing novel insight into the importance of fitness for
long-term CVD risk, particularly among persons with
elevated traditional risk factor burden.
Current study in context. Several prior studies have de-
scribed the association between levels of fitness and the risk
for CVD mortality, including the Lipid Research Clinics
Study (5), the Veteran Affairs Study (7), and previous
reports from the CCLS (3,4). These prior studies, as well as
a recent meta-analysis (6), have demonstrated a consistent,
inverse association between fitness and mortality in persons
with and without prevalent CVD at baseline and after
adjustment for traditional risk factors.
In general, these studies have applied conventional sta-
tistical techniques to provide both absolute and relative risk
estimates. Because these techniques censor data at the time
of a competing (non-CVD) death, they cannot be extrap-
olated to estimate cumulative risk across the lifespan when
competing risks can be substantial. In addition, relative and
absolute risk estimates have well-recognized limitations for
risk communication strategies (8–11,25–27). In particular,
relative risks require comparison to a base rate that is rarely
known in practice by patients or by physicians. Although sabsolute risks overcome this limitation, short-term absolute
risks do not reflect risks across the remaining lifespan (28).
The current study provides a clinically relevant and
ntuitive estimate of the association between fitness, tradi-
ional risk factors, and long-term risk. With the knowledge
f a man’s age, fitness, and risk factor status, clinicians can
rovide an estimate of the lifetime risk for CVD death. For
xample, consider a 55-year-old man able to walk 1 mile
n 15 min, consistent with very low fitness (METs 6).
With these data, we would predict that his lifetime risk
for CVD death was nearly 30%. In contrast, a man able
to run a 10-min mile (i.e., moderate fitness, or 10 METs)
would have an estimated lifetime risk of CVD mortality
of just 10%.
Study limitations. First, participants in the CCLS cohort
represent a unique sample of well-educated persons with a
relatively high socioeconomic status compared with the
general population. Therefore, these results may not gener-
alize to persons with a lower educational status or socioeco-
nomic level. However, the association between traditional
risk factor burden and lifetime risk observed in the CCLS at
ages 55 and 65 years were strikingly similar to those
obtained from a large, pooled cohort of 16 unique studies
(22). For men at these ages, we believe these findings are
generalizable to the broader population, extending prior
work on lifetime risks for CVD to include fitness—an
additional, modifiable lifestyle factor. However, the present
findings may not generalize to men at age 45 years, given
the overall lower lifetime risks for CVD in this subgroup.
Second, the ability to adequately control for competing
risks is reliable but somewhat limited using mortality from
death certificates because of the presence of misclassifica-
tions of non-CVD death as CVD death at older ages (29).
hus, we expect that adjudicated CVD deaths would have
ielded lower estimates across all risk groups, particularly
mong the highest fit groups. Therefore, we expect that the
ctual lifetime risks for CVD death among the highest fit
roups are actually lower than those reported in the present
aper.
Finally, we assessed the association between a single
easurement of fitness and the risk for CVD 30 years
ater. Although we acknowledge that fitness levels most
ertainly changed over the follow-up period, we feel that
his actually represents a significant strength of our findings.
n spite of these changes over time, a single measurement of
tness in mid-life represents a strong determinant of long-
erm CVD risk. These data provide additional support for
he importance of fitness in mid-life and could be useful in
fforts to promote risk communication.
onclusions
n summary, using a large, well-characterized cohort with
ong-term follow-up, we report the association between
tness levels and lifetime risks for CVD. In this study, a
ingle measurement of fitness in mid-life was associated
1610 Berry et al. JACC Vol. 57, No. 15, 2011
Lifetime Risk and Physical Fitness April 12, 2011:1604–10with marked differences in the lifetime risk for CVD
mortality 30 years later—particularly among persons with
at least 1 risk factor in mid-life. These data emphasize the
importance of fitness on long-term cardiovascular health
and could be useful for practicing clinicians to facilitate
more effective risk communication regarding the health
benefits of exercise.
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